Spooner Chad 4

What Happened Chad Spooner, Chief Financial Officer of MiniMed Group, Inc. (MMED), was granted two performance-based restricted stock unit awards on March 9, 2026 totaling 111,954 units (27,778 and 84,176). Each unit was granted at $0.00 (award/derivative), so there was no cash purchase; these are contingent awards that may convert into common shares if vesting and performance conditions are met.

Key Details

• Transaction date and price: 2026-03-09 — 27,778 PSUs @ $0.00 and 84,176 PSUs @ $0.00 (code A = Award/Grant).
• Total potential shares granted: 111,954 PSUs (each PSU = right to one share if conditions satisfied).
• Shares owned after transaction: not reported in this Form 4.
• Filing: Reported on March 11, 2026 for a March 9, 2026 grant — appears timely under Form 4 rules.
• Notable footnotes:
  • F1: Each PSU is a contingent right to one MMED share; these PSUs vest on March 9, 2027 only if MMED common stock achieves a closing price of at least $32.05 as of the specified Divestment Date (per the Separation Agreement dated March 1, 2026).
  • F2: Vesting occurs on the later of March 9, 2027 or the Divestment Date.
  • F3: (Related vesting schedule noted in the filing) an option vests 33% on March 9, 2028 and 33% on March 9, 2029, and 34% on March 9, 2030.

Context These awards are performance-based restricted stock units (PSUs), not immediate share purchases; they convert to shares only if time and performance/price conditions are met. Because the grants carry vesting and a stock-price hurdle, they do not reflect an immediate acquisition of shares and should be interpreted as compensation tied to future company performance rather than a direct bullish purchase by the insider.